PMID-40756949 – Emerging Use of BPC-157 in Orthopaedic Sports Medicine
Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM. "Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review," HSS J, 2025. doi:10.1177/15563316251355551
Quick Reference
| Property | Value |
|---|---|
| PMID | 40756949 |
| DOI | 10.1177/15563316251355551 |
| Year | 2025 |
| Journal | HSS Journal |
| Study Type | Systematic Review |
| Evidence Level | I |
| Sample | 36 studies analyzed (35 preclinical, 1 clinical) |
| Peptide(s) Studied | BPC-157 |
Key Findings
- Synthesized 36 studies on BPC-157 for musculoskeletal injuries; 35 were preclinical and only 1 was clinical
- BPC-157 enhances growth factor expression (VEGF, FGF, EGF) and promotes angiogenesis across multiple musculoskeletal tissue types
- Demonstrated efficacy in animal models of muscle, tendon, ligament, and bone injuries with consistent anti-inflammatory effects
- Limited human clinical safety data identified as a major gap; insufficient evidence to make clinical recommendations
- Published at Hospital for Special Surgery (HSS), a prestigious orthopedic institution
Study Design
Systematic review following PRISMA guidelines. Searched PubMed, Embase, and Cochrane databases for studies examining BPC-157 in musculoskeletal contexts. Included both preclinical and clinical studies without date restrictions. Quality assessment performed on included studies.
Limitations
- Overwhelmingly preclinical evidence (35/36 studies); only one clinical study identified
- Heterogeneity in animal models, dosing protocols, and outcome measures limits direct comparison
- Publication bias possible given most studies originate from a small number of research groups
- Unable to perform meta-analysis due to study heterogeneity
Clinical Relevance
This is the highest-level evidence synthesis available for BPC-157 in orthopedic/sports medicine. While preclinical results are consistently positive, the near-complete absence of human clinical data means no evidence-based clinical recommendations can be made. The systematic review methodology elevates this to Evidence Level I despite the preclinical nature of the underlying studies.
Related
#research #systematic-review #evidence-level-I